doi: 10.1161/hs1001.097093
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:2333.)
© 2001 American Heart Association, Inc.
Original Contributions |
Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
From the Department of Neurology, University Hospital Dijkzigt, Rotterdam, Netherlands (R.S., P.J.K.), and Department of Clinical Neurosciences, Western General Hospital, Edinburgh, United Kingdom (S.L., E.B., P.A.G.S.).
Correspondence to Ritu Saxena, MD, Department of Neurology, University Hospital Dijkzigt, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands. E-mail saxena{at}neuro.fgg.eur.nl
Background and Purpose—— We sought to investigate the apparently high risk of early death after an ischemic stroke among patients with atrial fibrillation (AF), identify the main factors associated with early death, and assess the effect of treatment with different doses of subcutaneous unfractionated heparin (UFH) given within 48 hours.
Methods—— We studied the occurrence of major clinical events within 14 days among 18 451 patients from the International Stroke Trial, first for all treatment groups combined. Then, among patients with AF, we examined the effects of treatment with subcutaneous UFH started within 48 hours and continued until 14 days after stroke onset.
Results—— A total of 3169 patients (17%) had AF. Seven hundred eighty-four patients were allocated to UFH 12 500 IU SC BID, 773 to UFH 5000 IU SC BID, and 1612 to no heparin. Within each of these groups, half of the patients were randomly assigned to aspirin 300 mg once daily. Compared with patients without AF, patients with AF were more likely to be female (56% versus 45%), to be old (mean age, 78 versus 71 years), to have an infarct on prerandomization CT (57% versus 47%), and to have impaired consciousness (37% versus 20%). The initial ischemic stroke type was more often a large-artery infarct (36% versus 21%). A lacunar stroke syndrome was less common (13% versus 26%). Death within 14 days was more common in patients with AF (17% versus 8%) and more often attributed to neurological damage from the initial stroke (10% versus 4%). The frequency of recurrent ischemic or undefined stroke was not significantly different (3.9% versus 3.3%). The proportion of AF patients with further events within 14 days allocated to UFH 12 500 IU (n=784), UFH 5000 IU (n=773), and to no-heparin (n=1612) groups were as follows: ischemic stroke, 2.3%, 3.4%, 4.9% (P=0.001); hemorrhagic stroke, 2.8%, 1.3%, 0.4% (P<0.0001); and any stroke or death, 18.8%, 19.4% and 20.7% (P=0.3), respectively. No effect of heparin on the proportion of patients dead or dependent at 6 months was apparent.
Conclusions—— Acute ischemic stroke patients with AF have a higher risk of early death, which can be explained by older age and larger infarcts but not by a higher risk of early recurrent ischemic stroke, although slightly more patients with AF died from a fatal recurrent stroke of ischemic or unknown type (1.3% versus 0.9%). In patients with AF the absolute risk of early recurrent stroke is low, and there is no net advantage to treatment with heparin. These data do not support the widespread use of intensive heparin regimens in the acute phase of ischemic stroke associated with AF.
Key Words: atrial fibrillation • heparin • mortality • randomized controlled trials • recurrence • stroke
This article has been cited by other articles:
 |
|
 |
|
  Y. Bejot, D. B. Salem, G. V. Osseby, G. Couvreur, J. Durier, C. Marie, Y. Cottin, T. Moreau, and M. Giroud Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 Neurology, January 27, 2009; 72(4): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Grad, H. Sievert, B. Nishri, G. W. Stone, B. T. Katzen, O. Yodfat, R. Higashida, D. Harris, A. K. Wakhloo, Y. Assaf, et al. A Novel Endovascular Device for Emboli Rerouting: Part I: Evaluation in a Swine Model Stroke, October 1, 2008; 39(10): 2860 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I van Wijk, P J Koudstaal, L J Kappelle, J van Gijn, J W Gorter, A Algra, and for the LiLAC Study Group Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 895 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N U Weir An update on cardioembolic stroke Postgrad. Med. J., March 1, 2008; 84(989): 133 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Prosser, L. MacGregor, K. R. Lees, H.-C. Diener, W. Hacke, S. Davis, and on behalf of the VISTA Investigators Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke Stroke, August 1, 2007; 38(8): 2295 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Roquer, A. Ois, A. Rodriguez-Campello, M. Gomis, E. Munteis, J. Jimenez-Conde, E. Cuadrado-Godia, and J. E. Martinez-Rodriguez Atherosclerotic Burden and Early Mortality in Acute Ischemic Stroke Arch Neurol, May 1, 2007; 64(5): 699 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rastas, A. Verkkoniemi, T. Polvikoski, K. Juva, L. Niinisto, K. Mattila, E. Lansimies, T. Pirttila, and R. Sulkava Atrial Fibrillation, Stroke, and Cognition: A Longitudinal Population-Based Study of People Aged 85 and Older Stroke, May 1, 2007; 38(5): 1454 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paciaroni, G. Agnelli, S. Micheli, and V. Caso Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials Stroke, February 1, 2007; 38(2): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Davis and G. A. Donnan Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: No, but .... Stroke, December 1, 2006; 37(12): 3056 - 3056. [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: Yes Stroke, December 1, 2006; 37(12): 3052 - 3053. [Full Text] [PDF]
|
|
|
|
|
|
J. Somerfield, P. A. Barber, N. E. Anderson, A. Kumar, D. Spriggs, A. Charleston, P. Bennett, Y. Baker, and L. Ross Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy Stroke, May 1, 2006; 37(5): 1217 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Boos, R. A. Anderson, and G. Y.H. Lip Is atrial fibrillation an inflammatory disorder? Eur. Heart J., January 2, 2006; 27(2): 136 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bushi, Y. Grad, S. Einav, O. Yodfat, B. Nishri, and D. Tanne Hemodynamic Evaluation of Embolic Trajectory in an Arterial Bifurcation: An In-Vitro Experimental Model Stroke, December 1, 2005; 36(12): 2696 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wani, E. Nga, and R. Navaratnasingham Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? BMJ, August 20, 2005; 331(7514): 439 - 442. [Full Text] [PDF]
|
|
|
|
|
|
C. Marini, F. De Santis, S. Sacco, T. Russo, L. Olivieri, R. Totaro, and A. Carolei Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study Stroke, June 1, 2005; 36(6): 1115 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Kimura, K Minematsu, T Yamaguchi, and for the Japan Multicenter Stroke Investigators' Co Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 679 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens Anticoagulation in atrial fibrillation and flutter Europace, January 1, 2005; 7(5): 492 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Thijs More bad news about atrial fibrillation Eur. Heart J., October 1, 2004; 25(19): 1670 - 1671. [Full Text] [PDF]
|
|
|
|
|
|
C. Steger, A. Pratter, M. Martinek-Bregel, M. Avanzini, A. Valentin, J. Slany, and C. Stollberger Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur. Heart J., October 1, 2004; 25(19): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Coull and P. M. Rothwell Underestimation of the Early Risk of Recurrent Stroke: Evidence of the Need for a Standard Definition Stroke, August 1, 2004; 35(8): 1925 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jabaudon, J. Sztajzel, K. Sievert, T. Landis, and R. Sztajzel Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack Stroke, July 1, 2004; 35(7): 1647 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. O'Rourke, N. Dean, N. Akhtar, and A. Shuaib Current and future concepts in stroke prevention Can. Med. Assoc. J., March 30, 2004; 170(7): 1123 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Mc Govern and A Rudd Management of stroke Postgrad. Med. J., February 1, 2003; 79(928): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Johnston Transient Ischemic Attack N. Engl. J. Med., November 21, 2002; 347(21): 1687 - 1692. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, S. Palacio, and L. A. Pearce Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials Stroke, November 1, 2002; 33(11): 2722 - 2727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O M P Jolobe and J M Wardlaw Radiology of stroke J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 96 - 96. [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Sadat, M. Sunbulli, and S. Chaturvedi Use of Intravenous Heparin by North American Neurologists: Do the Data Matter? Stroke, June 1, 2002; 33(6): 1574 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart and J. D. Easton Do We Really Need a Better Way to Give Heparin in Acute Cerebral Ischemia? Stroke, March 1, 2002; 33(3): 659 - 660. [Full Text] [PDF]
|
|